![Tom Palermo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Thomas J.
Palermo served as the Chief Executive Officer at ReVascular Therapeutics, Inc. and Ulcerx Medical, Inc. He also worked as the Vice President of Operations & Engineering at Ensure Medical, Inc. Palermo was the Chief Operating Officer at Dextera Surgical, Inc. from 2015 to 2018.
He completed his undergraduate degree from Southern New Hampshire University.
Former positions of Tom Palermo
Companies | Position | End |
---|---|---|
DEXTERA SURGICAL INC | Chief Operating Officer | 2018-02-28 |
Ensure Medical, Inc.
![]() Ensure Medical, Inc. Medical SpecialtiesHealth Technology Ensure Medical, Inc is a privately held company that develops devices for postcatheterization closure of the femoral artery. Its technology is based on a biodegradable closure device and a delivery system. The company was incorporated in 2002 and is headquartered in Sunnyvale, CA. | Chief Operating Officer | - |
Ulcerx Medical, Inc. | Chief Executive Officer | - |
ReVascular Therapeutics, Inc.
![]() ReVascular Therapeutics, Inc. Medical SpecialtiesHealth Technology ReVascular Therapeutics, Inc. used to develop and manufacture medical devices. It offers TRUEPATH, an intraluminal chronic total occlusion crossing device enabling endovascular treatment in cases that typically cannot be treated with standard endovascular devices. The company was founded in 2006 by Carl Simpson, Menahem Nassi and Gerardo V. Noriega and is headquartered in Sunnyvale, CA. | Chief Executive Officer | - |
Training of Tom Palermo
Southern New Hampshire University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Ensure Medical, Inc.
![]() Ensure Medical, Inc. Medical SpecialtiesHealth Technology Ensure Medical, Inc is a privately held company that develops devices for postcatheterization closure of the femoral artery. Its technology is based on a biodegradable closure device and a delivery system. The company was incorporated in 2002 and is headquartered in Sunnyvale, CA. | Health Technology |
ReVascular Therapeutics, Inc.
![]() ReVascular Therapeutics, Inc. Medical SpecialtiesHealth Technology ReVascular Therapeutics, Inc. used to develop and manufacture medical devices. It offers TRUEPATH, an intraluminal chronic total occlusion crossing device enabling endovascular treatment in cases that typically cannot be treated with standard endovascular devices. The company was founded in 2006 by Carl Simpson, Menahem Nassi and Gerardo V. Noriega and is headquartered in Sunnyvale, CA. | Health Technology |
Dex Liquidating Co.
![]() Dex Liquidating Co. Medical SpecialtiesHealth Technology Dextera Surgical, Inc. designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. It specializes in robotic-assisted surgery and medical devices. The company was founded by Bernard A. Hausen and Stephen A. Yencho on October 15, 1997 and is headquartered in Pleasanton, CA. | Health Technology |
Ulcerx Medical, Inc. |
- Stock Market
- Insiders
- Tom Palermo